Anavex Life Sciences Corp (AVXL)

[falconer66a]

Which Charts? TA or Clinical Outcomes

They [the shorts] also tend to ignore the fundamental science and just look at charts of the PAST.

Well, I have the contrary investment debility. I have no useful understanding of technical analysis (TA) plots, charts, or data of share prices or volumes. I can’t use any of that so-useful information to guide my investments in companies like Anavex Life Sciences Corp. I’m a biologist. I can understand the details and applications of the unique biochemistries of the Anavex molecules operating in neurons.

Will approval to sell Anavex 2-73 be controlled by precise and accurate plots of the AVXL share prices; or by the results of any of the on-going clinical trials? Does the FDA use the TA of a biotech’s share price to authorize sales of drug; or, analysis of the drug’s endpoints in approved clinical trials?

Let each weigh the information, interpret all of the data plots. In 2020, it will all be decided. Anavex Life Sciences Corp won’t be able to sell any of their drugs; or they will. Will TA of the AVXL share price history be in control of this? Or the science that controls the outcomes of any of the on-going clinical trials?